Donepezil SR 23 mg Tablets BE study [Study Per­for­mance]

posted by chaitanyag  – 2010-07-26 16:34 (5807 d 23:50 ago) – Posting: # 5680
Views: 13,091

Dear Members,

I need a clarifiction regarding Donepezil SR study. There was a high dropout rate (due to vomiting in pilot studies) observed with Donepezil SR 23mg formulation when dosed in healthy subjects. Recently Pfizer which got approval from FDA for Donepezil SR 23 mg submitted Phase III efficacy results in Alzheimers patients. I would be very much pleased if someone provide me any information on the feasibility of the study in India/USA. Can anyone provide me any data regarding the instituitions/CROs conducting such trials.

Thanking You in anticipation.

Awaiting your reply.

Regards,
Chaitanya

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
171 visitors (0 registered, 171 guests [including 24 identified bots]).
Forum time: 16:24 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5